These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 704471)
1. [Capilloroscopy of nail folds in Raynaud's syndrome during Hypacom treatment]. Bendkowski W; Bogdanowski T Pol Tyg Lek; 1978 Oct; 33(41):1619-20. PubMed ID: 704471 [No Abstract] [Full Text] [Related]
2. [Diagnosis and therapy of Raynaud's phenomenon (author's transl)]. Goebel KM; Neitzert A Ther Umsch; 1975 Jun; 32(6):350-6. PubMed ID: 806127 [No Abstract] [Full Text] [Related]
3. [Thermography in evaluating therapy in Raynaud's disease]. Litmanovitch J; Shilo R; Chayen M Harefuah; 1972 Jun; 82(11):503-6. PubMed ID: 5068900 [No Abstract] [Full Text] [Related]
4. [Dihydroergocristine in the treatment of Raynaud's disease]. Castelli PM; Sironi G Minerva Cardioangiol; 1977 Sep; 25(9):757-63. PubMed ID: 413069 [No Abstract] [Full Text] [Related]
5. [The vasoprostan treatment of patients with Raynaud's syndrome]. Alekperov RT; Mach ES; Guseva NG Ter Arkh; 1997; 69(8):22-3. PubMed ID: 9381386 [No Abstract] [Full Text] [Related]
6. [Study of the plethysmographic amplification factor during vasodilator treatment. Healthy subject versus primary Raynaud phenomenon]. Lasfargues G; Royere D; Perrotin D; Titon JP; Soutif D; Guilmot JL J Mal Vasc; 1987; 12(4):319-22. PubMed ID: 3694055 [TBL] [Abstract][Full Text] [Related]
7. Iloprost treatment of finger gangrene in a patient with Raynaud's syndrome. Levy Y; Sherer Y; Shoenfeld Y Isr Med Assoc J; 2000 Dec; 2(12):960-1. PubMed ID: 11344792 [No Abstract] [Full Text] [Related]
9. Oral sildenafil for the treatment of Raynaud's phenomenon and digital ulcers secondary to systemic sclerosis. Gore J; Silver R Ann Rheum Dis; 2005 Sep; 64(9):1387. PubMed ID: 16100356 [No Abstract] [Full Text] [Related]
10. Iloprost treatment for refractory Raynaud's phenomenon in two infants. Shouval DS; Mukamel M; Zulian F; Amir J; Harel L Clin Exp Rheumatol; 2008; 26(3 Suppl 49):S105-7. PubMed ID: 18799065 [TBL] [Abstract][Full Text] [Related]
11. [The effect of beraprost sodium on the Raynaud's phenomenon]. Hiida M; Ushiyama O; Suzuki N; Ohta A; Nagasawa K; Yamaguchi M Nihon Rinsho Meneki Gakkai Kaishi; 1996 Jun; 19(3):193-200. PubMed ID: 8810544 [TBL] [Abstract][Full Text] [Related]
12. [Parameters for the measurement of long-term effects of an orally administered drug in organic and functional circulatory disorders. Preliminary communication]. Schuster CJ; von Ungern-Sternberg AF ZFA (Stuttgart); 1976 Jan; 52(2):105-10. PubMed ID: 817527 [No Abstract] [Full Text] [Related]
13. Medical treatment in Raynaud's disease. Hansteen V Acta Chir Scand Suppl; 1976; 465():87-91. PubMed ID: 793268 [No Abstract] [Full Text] [Related]
19. [Local administration of cerebrolysin in Raynaud's disease in a 2-year-old child]. Osipenko TN; Skvortsov IA; Korshunov SV Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(8):100-3. PubMed ID: 1661499 [TBL] [Abstract][Full Text] [Related]